A novel non-peptidic agonist of the ghrelin receptor with orexigenic activity in vivo
dc.contributor.author | Pastor-Cavada, Elena | |
dc.contributor.author | Pardo, Leticia M. | |
dc.contributor.author | Kandil, Dalia | |
dc.contributor.author | Torres-Fuentes, Cristina | |
dc.contributor.author | Clarke, Sarah L. | |
dc.contributor.author | Shaban, Hamdy | |
dc.contributor.author | McGlacken, Gerard P. | |
dc.contributor.author | Schellekens, Harriƫt | |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | Irish Research Council for Science, Engineering and Technology | en |
dc.contributor.funder | Universidad de Sevilla | en |
dc.contributor.funder | Pfizer Process Development Centre, Cork | |
dc.date.accessioned | 2016-12-12T17:24:16Z | |
dc.date.available | 2016-12-12T17:24:16Z | |
dc.date.issued | 2016-11-07 | |
dc.date.updated | 2016-12-09T12:52:42Z | |
dc.description.abstract | Loss of appetite in the medically ill and ageing populations is a major health problem and a significant symptom in cachexia syndromes, which is the loss of muscle and fat mass. Ghrelin is a gut-derived hormone which can stimulate appetite. Herein we describe a novel, simple, non-peptidic, 2-pyridone which acts as a selective agonist for the ghrelin receptor (GHS-R1a). The small 2-pyridone demonstrated clear agonistic activity in both transfected human cells and mouse hypothalamic cells with endogenous GHS-R1a receptor expression. In vivo tests with the hit compound showed significant increased food intake following peripheral administration, which highlights the potent orexigenic effect of this novel GHS-R1a receptor ligand. | en |
dc.description.sponsorship | Science Foundation Ireland (SFI/12/IP/1315 and SFI/12/RC/2275); Irish Research Council for Science and Technology and Pfizer Process Development Centre, Cork (Enterprise Partnership Scheme) | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | 36456 | |
dc.identifier.citation | Pastor-Cavada, E., Pardo, L. M., Kandil, D., Torres-Fuentes, C., Clarke, S. L., Shaban, H., McGlacken, G. P. and Schellekens, H. (2016) 'A novel non-peptidic agonist of the ghrelin receptor with orexigenic activity in vivo', Scientific Reports, 6, 36456 (13pp). doi:10.1038/srep36456 | en |
dc.identifier.doi | 10.1038/srep36456 | |
dc.identifier.endpage | 13 | en |
dc.identifier.issn | 2045-2322 | |
dc.identifier.journaltitle | Scientific Reports | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/3370 | |
dc.identifier.volume | 6 | en |
dc.language.iso | en | en |
dc.publisher | Nature Publishing Group | en |
dc.rights | Ā© 2016, the Authors. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the articleās Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Growth hormone secretagogue | en |
dc.subject | Food intake | en |
dc.subject | Medicinal chemistry | en |
dc.subject | Older adults | en |
dc.subject | Mechanisms | en |
dc.subject | Secretion | en |
dc.subject | Fluorine | en |
dc.subject | Peptide | en |
dc.subject | Healthy | en |
dc.subject | Anorexia-cachexia | en |
dc.title | A novel non-peptidic agonist of the ghrelin receptor with orexigenic activity in vivo | en |
dc.type | Article (peer-reviewed) | en |